C12N 2770/32121
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/32121 (Viruses as such) appears on 7 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 7
- Assignees
- 6
- Inventors
- 35
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 2 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof9 Apr 2024US 11,952,401 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Recombinant virus capable of stably expressing target proteins20 Feb 2024US 11,904,010 B2Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof24 Oct 2023US 11,793,870 B2Codagenix Inc.
- Temperature-sensitive attenuated FMDV strains, construction method and application thereof16 Feb 2021US 10,918,710 B2Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof19 Jan 2021US 10,894,081 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Development of mosaic vaccines against foot and mouth disease virus serotype asia1 May 2025US 2025/0134984 A1
- Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof20 Jan 2022US 2022/0017576 A1Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof30 Dec 2021US 2021/0401967 A1Codagenix Inc.
- Recombinant virus capable of stably expressing target proteins18 Nov 2021US 2021/0353734 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Recombinant Bivalent Inactivated Vaccine Against Foot-and-Mouth Disease Virus, Preparation Method and Use Thereof30 Jul 2020US 2020/0237897 A1Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Most cited
By later US patents
- Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof1US 10,894,081 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences · 2021
- Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host1US 8,765,141 B2The United States of America as represented by the Secretary of Agriculture · 2014
- Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host1US 9,180,179 B1The United States of America as represented by the Secretary of Agriculture · 2015